MOVEMENT DISORDERS
A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.
1 . A method of treating movement disorders, including the steps of:
administering an effective amount of a psychedelic to an individual having a movement disorder; and
treating the movement disorder.
2 . The method of claim 1 , wherein the movement disorder is chosen from the group consisting of ataxia, cervical dystonia, chorea, dystonia, functional movement disorder, Huntington's disease, multiple system atrophy, myoclonus, Parkinson's disease, Parkinsonism, progressive supranuclear palsy, restless legs syndrome, spasticity, tardive dyskinesia, tic disorders, tremor, and Wilson's disease.
3 . The method of claim 1 , wherein the psychedelic is chosen from the group consisting of lysergic acid diethylamide (LSD), psilocybin, psilocin, mescaline, 3,4-methylenedioxymethamphetamine (MDMA), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), dimethyltryptamine (DMT), 2,5-dimethoxy-4-iodoamphetamine (DOI), 2,5-dimethoxy-4-bromoamphetamie (DOB), salts thereof, tartrates thereof, solvates thereof, isomers thereof, analogs thereof, homologues thereof, or deuterated forms thereof.
4 . The method of claim 1 , wherein said treating step further includes the step of reducing and/or eliminating undesired movement or tremors.
5 . The method of claim 1 , wherein said treating step further includes the step of returning abnormal movement to a normal state.
6 . The method of claim 1 , wherein said treating step further includes the step of reducing anxiety and reducing abnormal movement due to anxiety.
7 . The method of claim 1 , wherein said treating step further includes the step of reducing tremors due to side effects of drugs that the individual is taking.